Nerve Growth Factor (NGF) Inhibitors and Related Agents for Chronic Musculoskeletal Pain: A Comprehensive Review

2021/11/01 by Win Min Oo, David J. Hunter, David J Hunter · 1 citation
Medicine · #Musculoskeletal pain and rehabilitation #Pain Mechanisms and Treatments #Spine and Intervertebral Disc Pathology

paper · doi:10.1007/s40259-021-00504-8

crossref issued 2021/11/01 · crossref published 2021/11/01 · crossref published-print 2021/11/01 · openalex publication_date 2021/11/01 · crossref published-online 2021/11/22 · crossref created 2021/11/22 · crossref deposited 2023/02/09 · openalex created_date 2025/10/10 · crossref indexed 2026/03/05 · openalex updated_date 2026/07/29

Citations

• Lifetime risk of symptomatic knee osteoarthritis
• A systematic review of the global prevalence of low back pain
• OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis
• Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Cited by

• Nerve growth factor inhibitor [wikipedia]